Figure 6From: Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cellsConfocal images of p65 in cells after the treatment of DOX (A) and PTX (B) with or without Bay 11–7082 inhibition and TLR4 antibody blocking. Cells were stained with Dylight 488 (green fluorescence) for p65 and co-stained with DAPI (blue) for positive identification of nuclei. The cells (arrow) are also enlarged at single-cell level for clarification (right images).Back to article page